Lifeward Ltd.
$7.52
▲
0.88%
2026-04-21 07:52:01
golifeward.com
NCM: LFWD
Explore Lifeward Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$11.49 M
Current Price
$7.52
52W High / Low
$18.6 / $4.14
Stock P/E
—
Book Value
$5.52
Dividend Yield
—
ROCE
-155.52%
ROE
-1.46%
Face Value
—
EPS
$-17.16
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
81
Beta
0.16
Debt / Equity
52.18
Current Ratio
1.31
Quick Ratio
0.84
Forward P/E
-5.21
Price / Sales
1.13
Enterprise Value
$12.26 M
EV / EBITDA
-0.71
EV / Revenue
0.56
Rating
None
Target Price
$20
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | WORK Medical Technology Group LTD | $1.2 | — | $1.6 M | — | -4.23% | -6.45% | $10,800 / $1.05 | $17.7 |
| 2. | Bruker Corporation | $41.1 | — | $6.23 B | 0.49% | 4.76% | -0.38% | $56.22 / $28.53 | $16.15 |
| 3. | RxSight, Inc. | $7.44 | — | $314.04 M | — | -16.88% | -13.98% | $16.74 / $5.9 | $6.68 |
| 4. | InMode Ltd. | $14.57 | 9.84 | $923.14 M | — | 12.27% | 13.53% | $16.74 / $12.72 | $10.78 |
| 5. | iRhythm Holdings, Inc. | $124.91 | — | $4.04 B | — | -5.75% | -36.57% | $212 / $97.16 | $4.73 |
| 6. | Myomo, Inc. | $0.9 | — | $34.65 M | — | -47.54% | -86.24% | $4.99 / $0.6 | $0.3 |
| 7. | Haemonetics Corporation | $61.17 | 16.14 | $2.83 B | — | 10.74% | 19.3% | $87.32 / $47.31 | $19.46 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 5.08 M | 6.2 M | 5.72 M | 5.03 M | 7.54 M | — |
| Operating Profit | -5.12 M | -3.14 M | -3.78 M | -4.85 M | -5.43 M | — |
| Net Profit | -5.35 M | -3.17 M | -6.56 M | -4.83 M | -15.28 M | — |
| EPS in Rs | -1.41 | -0.84 | -1.73 | -1.28 | -4.04 | -4.2 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 22.03 M | 25.66 M | 13.85 M | 5.51 M |
| Operating Profit | -16.89 M | -19.55 M | -23.61 M | -19.1 M |
| Net Profit | -19.91 M | -28.94 M | -22.13 M | -19.57 M |
| EPS in Rs | -5.26 | -7.65 | -5.85 | -5.17 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 22.9 M | 30.49 M | 63.19 M | 74.24 M |
| Total Liabilities | 14.49 M | 11.64 M | 16.68 M | 6.07 M |
| Equity | 8.41 M | 18.85 M | 46.51 M | 68.17 M |
| Current Assets | 15.81 M | 21.29 M | 39.22 M | 72.51 M |
| Current Liabilities | 12.04 M | 10.22 M | 11.79 M | 4.78 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -16.83 M | -21.72 M | -20.67 M | -17.89 M |
| Investing CF | -0.02 M | 0 M | -18.15 M | -0.03 M |
| Financing CF | 12.2 M | 0 M | -0.99 M | -2.5 M |
| Free CF | -16.84 M | -21.72 M | -20.75 M | -17.92 M |
| Capex | -0.02 M | — | -0.08 M | -0.03 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 85.24% | 151.39% | — | — |
| Earnings Growth % | -30.76% | -13.1% | — | — |
| Profit Margin % | -112.78% | -159.76% | -355.09% | — |
| Operating Margin % | -76.19% | -170.43% | -346.62% | — |
| Gross Margin % | 32.01% | 32.14% | 34.57% | — |
| EBITDA Margin % | -61.22% | -157.1% | -342.95% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-02-24 | 1:0.0833333 |
| 2024-03-15 | 1:0.142857 |